Myeloid-derived-suppressor cells as regulators of the immune system

Cited by (1,052)

Items 601–700 of 1,052

1. Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy
   Yiliang Li, Sapna Pradyuman Patel, Jason Roszik, Yong Wen Qin · 2018 · Frontiers in Immunology
2. Global immune fingerprinting in glioblastoma patient peripheral blood reveals immune-suppression signatures associated with prognosis
   Tyler Joseph Alban, Alvaro G. Alvarado, Mia Dahl Sørensen, Defne Bayık, Josephine Volovetz, Emily Serbinowski, Erin E. Mulkearns-Hubert, Maksim Sinyuk, James S. Hale, Giovana R. Onzi et al. · 2018 · JCI Insight
3. Scientific Rationale for Combined Immunotherapy with PD-1/PD-L1 Antibodies and VEGF Inhibitors in Advanced Hepatocellular Carcinoma
   Masatoshi Kudo · 2020 · Cancers
4. Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma
   Noel, Marcus, O’Reilly, Eileen M., Wolpin, Brian M., Ryan, David P., Bullock, Andrea J., Britten, Carolyn D., Linehan, David C., Belt, Brian A., Gamelin, Eric C., Ganguly, Bishu et al. · 2020 · Investigational New Drugs
5. Involvement of a Non-Human Sialic Acid in Human Cancer
   Samraj, Annie N., Läubli, Heinz, Varki, Nissi, Varki, Ajit · 2014 · Frontiers in Oncology
6. Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α
   Yana George Najjar, Patricia A. Rayman, Xuefei Jia, Paul G. Pavicic, Brian I. Rini, Charles S. Tannenbaum, Jennifer S. Ko, Samuel Haywood, Peter A. Cohen, Thomas A. Hamilton et al. · 2016 · Clinical Cancer Research
7. Tumor microenvironment: a main actor in the metastasis process
   Daniela Spano, Massimo Zollo · 2012 · Clinical & Experimental Metastasis
8. Efficient Capture of Infected Neutrophils by Dendritic Cells in the Skin Inhibits the Early Anti-Leishmania Response
   Flávia Lima Ribeiro-Gomes, Nathan C. Peters, Alain Debrabant, David L. Sacks · 2012 · PLoS Pathogens
9. Myeloid Suppressor Cells Induced by Hepatitis C Virus Suppress T-Cell Responses Through the Production of Reactive Oxygen Species
   Robert Tacke, Hai-Chon Lee, Celeste G. Yergin, Jeremy Courtney, Stephen J. Polyak, Hugo R. Rosen, Young S. Hahn · 2011 · Hepatology
10. Deletion of p120-Catenin Results in a Tumor Microenvironment with Inflammation and Cancer that Establishes It as a Tumor Suppressor Gene
    Douglas B. Stairs, Lauren J. Bayne, Ben Rhoades, Maria E. Vega, Todd J. Waldron, Jiří Kalabis, Andres J. Klein–Szanto, Ju‐Seog Lee, Jonathan P. Katz, John Alan Diehl et al. · 2011 · Cancer Cell
11. Tumor microenvironment: The culprit for ovarian cancer metastasis?
    Zhongyue Luo, Qiu Wang, Wayne Bond Lau, Bonnie Lau, Lian Xu, Linjie Zhao, Huiliang Yang, Min Feng, Xuan Yu, Yanfei Yang et al. · 2016 · Cancer Letters
12. Specific and Complex Reprogramming of Cellular Metabolism in Myeloid Cells during Innate Immune Responses
    Rinke Stienstra, Romana Teodora Netea-Maier, Niels Peter Riksen, Leo A. B. Joosten, Mihai Gheorghe Netea · 2017 · Cell Metabolism
13. Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells
    Lintao Zhao, Ran He, Haixia Long, Bo Guo, Qingzhu Jia, Diyuan Qin, Si-Qi Liu, Zhongyu Wang, Tong Xiang, Jue Zhang et al. · 2018 · Nature Medicine
14. Anti-inflammatory cytokines in endometriosis
    Wen‐Jie Zhou, Hui‐Li Yang, Jun Shao, Jie Mei, Kai‐Kai Chang, Rui Zhu, Ming‐Qing Li · 2019 · Cellular and Molecular Life Sciences
15. Vascular remodeling in cancer
    Rae H. Farnsworth, Martin Lackmann, Marc G. Achen, Steven A. Stacker · 2013 · Oncogene
16. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia
    Athalia Rachel Pyzer, Dina Stroopinsky, Hasan N. Rajabi, Abigail J. Washington, Ashujit Tagde, Maxwell Douglas Coll, Jacqueline Fung, Mary Paty Bryant, Leandra Cole, Kristen Anna Palmer et al. · 2017 · Blood
17. Melanoma-Educated CD14+ Cells Acquire a Myeloid-Derived Suppressor Cell Phenotype through COX-2–Dependent Mechanisms
    Yumeng Mao, Isabel C. Poschke, Erik Wennerberg, Yago Pico de Coaña, Suzanne Egyhazi Brage, Inkeri Schultz, Johan Hansson, Giuseppe Valentino Masucci, Andreas Lundqvist, Rolf W. Kiessling · 2013 · Cancer Research
18. Long-term pulmonary exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades
    Xuefei Lu, Yong Zhu, Ru Bai, Zhengsheng Wu, Wenchang Qian, Leiyan Yang, Rong Cai, Hong Yan, Tao Li, Vijay Pandey et al. · 2019 · Nature Nanotechnology
19. GM-CSF Promotes the Immunosuppressive Activity of Glioma-Infiltrating Myeloid Cells through Interleukin-4 Receptor-α
    Gary Kohanbash, Kayla McKaveney, Masashi Sakaki, Ryo Ueda, Arlan H. Mintz, Nduka A. Amankulor, Mitsugu Fujita, John R. Ohlfest, Hideho Okada · 2013 · Cancer Research
20. Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
    Laura Jeanbart, Marie Christine Ballester, Alexandre de Titta, Patricia Corthésy, Pedro J. Romero, Jeffrey A. Hubbell, Melody A. Swartz · 2014 · Cancer Immunology Research
21. Arginase-1–dependent promotion of T H 17 differentiation and disease progression by MDSCs in systemic lupus erythematosus
    Hao Wu, Zhen Yu, Zhanchuan Ma, Huimin Li, Jinyu Yu, Zhonggao Xu, Xiang‐Yang Wang, Huanfa Yi, Yong‐Guang Yang · 2016 · Science Translational Medicine
22. Cellular Innate Immunity: An Old Game with New Players
    Georg Gasteiger, Andrea D’Osualdo, David A. Schubert, Alexander N.R. Weber, Emanuela M. Bruscia, Dominik Hartl · 2016 · Journal of Innate Immunity
23. The interplay of immunology and cachexia in infection and cancer
    Hatoon Baazim, Laura Antonio-Herrera, Andreas Bergthaler · 2021 · Nature reviews. Immunology
24. Tumor Abnormality-Oriented Nanomedicine Design
    Quan Zhou, Jiajia Xiang, Nasha Qiu, Yechun Wang, Ying Piao, Shiqun Shao, Jianbin Tang, Zhuxian Zhou, Youqing Shen · 2023 · Chemical Reviews
25. Contribution of adipose tissue to development of cancer
    Cozzo, Alyssa J., Fuller, Ashley M., Makowski, Liza · 2017 · Comprehensive Physiology
26. Recent Developments in Cancer Vaccines
    Karolina Palucka, Hideki Ueno, Jacques Banchereau · 2011 · The Journal of Immunology
27. Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients
    Christabelle J. Darcy, Gabriela Minigo, Kim A. Piera, Joshua Saul Davis, Yvette McNeil, Youwei Chen, Alicia D. Volkheimer, Joe Brice Weinberg, Nicholas M. Anstey, Tonia Woodberry · 2014 · Critical Care
28. Impact of the immune system and immunotherapy in colorectal cancer.
    Janet L. Markman, Stephen Lawrence Shiao · 2015 · PubMed Central
29. Myeloid-derived suppressor cells express Bruton's tyrosine kinase and can be depleted in tumor-bearing hosts by ibrutinib treatment
    Stiff, Andrew, Trikha, Prashant, Wesolowski, Robert, Kendra, Kari, Hsu, Vincent, Uppati, Sarvani, McMichael, Elizabeth, Duggan, Megan, Campbell, Amanda, Keller, Karen et al. · 2016 · Cancer Research
30. A nervous tumor microenvironment: the impact of adrenergic stress on cancer cells, immunosuppression, and immunotherapeutic response
    Jason W.‐L. Eng, Kathleen M. Kokolus, Chelsey B. Reed, Bonnie Lee Hylander, Wen W. Ma, Elizabeth A. Repasky · 2014 · Cancer Immunology Immunotherapy
31. Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy
    Xinmei Zhu, Mitsugu Fujita, Linda A. Snyder, Hideho Okada · 2010 · Journal of Neuro-Oncology
32. Myeloid-Derived Suppressor Cell Inhibition of the IFN Response in Tumor-Bearing Mice
    Bethany L. Mundy-Bosse, Gregory B. Lesinski, Alena Cristina Jaime‐Ramirez, Kristen L. Benninger, Mahmood Khan, Periannan Kuppusamy, Kristan D. Guenterberg, Sri Vidya Kondadasula, Abhik Ray Chaudhury, Krista M. D. La Perle et al. · 2011 · Cancer Research
33. TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients
    Dewan Md Sakib Hossain, Sumanta Kumar Pal, Dayson Moreira, Priyanka A. Duttagupta, Qifang Zhang, Haejung Won, Jeremy O. Jones, Massimo D’Apuzzo, Stephen J. Forman, Marcin Kortylewski · 2015 · Clinical Cancer Research
34. Sepsis in the burn patient: a different problem than sepsis in the general population
    David G. Greenhalgh · 2017 · Burns & Trauma
35. Radiotherapy, immunotherapy, and the tumour microenvironment: Turning an immunosuppressive milieu into a therapeutic opportunity
    NE Donlon, Robert F. Power, Conall Hayes, John Vincent Reynolds, Joanne Lysaght · 2021 · Cancer Letters
36. The tumor microenvironment in hepatocellular carcinoma (Review)
    Massimo Libra · 2012 · International Journal of Oncology
37. The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma
    Ryan A. Wilcox, Kay M. Ristow, Thomas Matthew Habermann, David James Inwards, I.N. Micallef, Patrick B. Johnston, J P Colgan, Grzegorz S. Nowakowski, Stephen Maxted Ansell, Thomas Elmer Witzig et al. · 2011 · Leukemia
38. The Liver Is a Site for Tumor-Induced Myeloid-Derived Suppressor Cell Accumulation and Immunosuppression
    Dan Ilkovitch, Diana M. Lopez · 2009 · Cancer Research
39. Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer
    Oxana Dmitrieva-Posocco, Amiran Dzutsev, David F. Posocco, Vivianty Hou, Wuxing Yuan, Vishal Thovarai, Ilgiz A. Mufazalov, Matthias Gunzer, Igor P. Shilovskiy, Musa Rakhimovich Khaitov et al. · 2019 · Immunity
40. MEK inhibitor resistance mechanisms and recent developments in combination trials
    Eucharist Kun, Yvonne T.M. Tsang, Chun Wai Ng, David Marc Gershenson, Kwong‐Kwok Wong · 2020 · Cancer Treatment Reviews
41. On the cytokines produced by human neutrophils in tumors
    Cristina Tecchio, Patrizia Scapini, Giovanni Pizzolo, Marco Antonio Cassatella · 2013 · Seminars in Cancer Biology
42. Role of Inflammation and Immunity in Hypertension: Recent Epidemiological, Laboratory, and Clinical Evidence
    Antoine Caillon, Ernesto L. Schiffrin · 2016 · Current Hypertension Reports
43. Neutrophils in traumatic brain injury (TBI): friend or foe?
    Yang‐Wuyue Liu, Song Li, Shuang-Shuang Dai · 2018 · Journal of Neuroinflammation
44. Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy
    Pedro Bule, Sandra Isabel Aguiar, Frederico Aires‐da‐Silva, Joana Dias · 2021 · International Journal of Molecular Sciences
45. Immune Checkpoint Inhibitors in EGFR-Mutated NSCLC: Dusk or Dawn?
    Qiao, Meng, Jiang, Tao, Liu, Xinyu, Mao, Shiqi, Zhou, Fei, Li, Xuefei, Zhao, Chao, Chen, Xiaoxia, Su, Chunxia, Ren, Shengxiang et al. · 2021 · Journal of Thoracic Oncology
46. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells
    Yinan Deng, Jintao Cheng, Binsheng Fu, Wen Liu, Guangzi Chen, Qi Zhang, Yuebo Yang · 2016 · Oncogene
47. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma
    Tamar G. Kapanadze, Jaba Gamrekelashvili, Chi Ma, Carmen Chan, Fei Zhao, Stephen M. Hewitt, Lars Zender, Veena Kapoor, Dean W. Felsher, Michael Peter Manns et al. · 2013 · Journal of Hepatology
48. Multiple myeloma in the marrow: pathogenesis and treatments
    Heather E. Fairfield, Carolyne R. Falank, Lindsey M. Avery, Michaela Ruth Reagan · 2016 · Annals of the New York Academy of Sciences
49. Co-delivery of Bee Venom Melittin and a Photosensitizer with an Organic–Inorganic Hybrid Nanocarrier for Photodynamic Therapy and Immunotherapy
    Haojie Liu, Yan Hu, Yajie Sun, Chao Wan, Zhanjie Zhang, Xiaomeng Dai, Zihan Lin, Qianyuan He, Zhe Yang, Piao Huang et al. · 2019 · ACS Nano
50. Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma
    Chang Gon Kim, Chan Kim, Sang Eun Yoon, Kyung Hwan Kim, Seong Jin Choi, Beodeul Kang, Hye Ryun Kim, Su‐Hyung Park, Eui‐Cheol Shin, Yeun‐Yoon Kim et al. · 2020 · Journal of Hepatology
51. Pulmonary Alveolar Macrophages Contribute to the Premetastatic Niche by Suppressing Antitumor T Cell Responses in the Lungs
    Sharad Sharma, Navin K. Chintala, Surya Kumari Vadrevu, Jalpa Patel, Magdalena Karbowniczek, Maciej M. Markiewski · 2015 · The Journal of Immunology
52. Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer
    Manja Idorn, Tania Køllgaard, Per Kongsted, Lisa Sengeløv, Per thor Straten · 2014 · Cancer Immunology Immunotherapy
53. Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
    Joseph A. Califano, Zubair Hanif Khan, Kimberly Ann Noonan, Lakshmi Rudraraju, Zhe Zhang, Hao Wang, Steven N. Goodman, Christine Gail Gourin, Patrick K. Ha, Carole Fakhry et al. · 2015 · Clinical Cancer Research
54. Targeting microRNAs as key modulators of tumor immune response
    Laura Paladini, Linda Fabris, Giulia Bottai, Carlotta Raschioni, George A. Călin, Libero Santarpia · 2016 · Journal of Experimental & Clinical Cancer Research
55. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
    Shiou-Ling Jian, Weiwei Chen, Yu‐Chia Su, Yu‐Wen Su, Tsung‐Hsien Chuang, Shu‐Ching Hsu, Li–Rung Huang · 2017 · Cell Death and Disease
56. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells
    Ying Zhu, Anni Wang, Shuya Zhang, Jisu Kim, Jiaxuan Xia, Fengxue Zhang, Dan Wang, Qi Wang, Jianxin Wang · 2022 · Journal of Advanced Research
57. In vivo Gold Nanoparticle Delivery of Peptide Vaccine Induces Anti‐Tumor Immune Response in Prophylactic and Therapeutic Tumor Models
    Joao Paulo Mattos Almeida, Adam Yuh Lin, Elizabeth Raquel Figueroa, Aaron Edward Foster, Rebekah Anna Drezek · 2014 · Small
58. Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer
    Anandi Sawant, Jessy S. Deshane, Joel Jules, Carnella M. Lee, Brittney A. Harris, Xu Feng, Selvarangan Ponnazhagan · 2012 · Cancer Research
59. Improving Cancer Immunotherapy by Cell Membrane‐Camouflaged Nanoparticles
    Ziling Zeng, Kanyi Pu · 2020 · Advanced Functional Materials
60. Hypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
    Salem Chouaı̈b, Yosra Messai, Sophie Couvé, Bernard J. Escudier, Meriem Hasmim, Muhammad Zaeem Noman · 2012 · Frontiers in Immunology
61. Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
    Maria Florencia Mercogliano, Sofía Bruni, Patricia V. Elizalde, Roxana Schillaci · 2020 · Frontiers in Oncology
62. Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation
    Michael C. Schmid, Judith A. Varner · 2010 · Journal of Oncology
63. Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers
    Roni Allaoui, Caroline Bergenfelz, Sofie Mohlin, Catharina Hagerling, Kiarash Salari, Zena Werb, Robin L. Anderson, Stephen P. Ethier, Karin Jirström, Sven Påhlman et al. · 2016 · Nature Communications
64. VISTA is highly expressed on MDSCs and mediates an inhibition of T cell response in patients with AML
    Liru Wang, Bei Jia, David F. Claxton, William Christopher Ehmann, Witold B. Rybka, Shin Mineishi, Seema G Naik, Muhammad Rizwan Khawaja, Jeff Sivik, Junyan Han et al. · 2018 · OncoImmunology
65. Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes
    Ling Li, Bangrong Cao, Xin‐hua Liang, Shun Lu, Huaichao Luo, Zhaohui Wang, Shaoxin Wang, Jian Dong Jiang, Jinyi Lang, Guiquan Zhu · 2018 · Oncogene
66. The role of polyamines in the regulation of macrophage polarization and function
    Yvonne L. Latour, Alain P. Gobert, Keith T. Wilson · 2019 · Amino Acids
67. Hypoxia and HIF Signaling: One Axis with Divergent Effects
    Chiara Corrado, Simona Fontana · 2020 · International Journal of Molecular Sciences
68. Predictive clinical outcome of the intratumoral CD66b‐positive neutrophil‐to‐CD8‐positive T‐cell ratio in patients with resectable nonsmall cell lung cancer
    Marius Ilié, Véronique Hofman, Cécile Ortholan, Christelle Bonnetaud, Céline Coëlle, Jérôme Mouroux, Paul M Hofman · 2011 · Cancer
69. MicroRNA-155 and MicroRNA-21 Promote the Expansion of Functional Myeloid-Derived Suppressor Cells
    Limin Li, Jing Zhang, Wenli Diao, Dong Wang, Wei Yao, Chen‐Yu Zhang, Ke Zen · 2014 · The Journal of Immunology
70. Myeloid-Derived Suppressor Cells Evolve during Sepsis and Can Enhance or Attenuate the Systemic Inflammatory Response
    Laura E. Brudecki, Donald A. Ferguson, Charles E. McCall, Mohamed El Gazzar · 2012 · Infection and Immunity
71. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1
    Zhifa Wen, Hongxiang Liu, Rong Gao, Meng Zhou, Jie Ma, Yue Zhang, Jinjin Zhao, Yongqiang Chen, Tianyu Zhang, Fang Huang et al. · 2018 · Journal for ImmunoTherapy of Cancer
72. Recent advances in the mechanisms and treatment of immune thrombocytopenia
    Drew Provan, John W. Semple · 2022 · EBioMedicine
73. Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment
    Esther Schoutrop, Lidia Moyano‐Galceran, Stéphanie Lheureux, Jonas Mattsson, Kaisa Lehti, Hanna Mellin Dahlstrand, Isabelle Magalhaes · 2022 · Seminars in Cancer Biology
74. Arginase 1 is a key driver of immune suppression in pancreatic cancer
    Rosa Elena Menjivar, Zeribe C. Nwosu, Wenting Du, Katelyn L. Donahue, Hanna S. Hong, Carlos E. Espinoza, Kristee L. Brown, Ashley Velez-Delgado, Wei Yan, Fatima Lima et al. · 2023 · eLife
75. Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer
    Nicolò Bancaro, Bianca Calì, Martina Troiani, Angela Rita Elia, Rydell Alvarez Arzola, Giuseppe Attanasio, Ping Lai, Mateus Crespo, Bora Gürel, Rita Pereira et al. · 2023 · Cancer Cell
76. Lessons from patient-derived xenografts for better in vitro modeling of human cancer
    Stephen Yiu Chuen Choi, Dong Lin, Peter W. Gout, Colin C. Collins, Yong Xu, Yuzhuo Z. Wang · 2014 · Advanced Drug Delivery Reviews
77. CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors
    Amy Hughes, Jade Clarson, Carine Tang, Ljiljana Vidovic, Deborah L. White, Timothy P. Hughes, Agnes S. M. Yong · 2017 · Blood
78. Mass Cytometry Imaging for the Study of Human Diseases—Applications and Data Analysis Strategies
    Heeva Baharlou, Nicolas P. Canete, Anthony Lawrence Cunningham, Andrew Nicholas Harman, Ellis Patrick · 2019 · Frontiers in Immunology
79. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner
    Zhang, Qian-Feng, Li, Jia, Jiang, Kuo, Wang, Rui, Ge, Jun-li, Yang, Hong, Liu, Shu-Juan, Jia, Lin-Tao, Wang, Lei, Chen, Bi-Liang · 2020 · Theranostics
80. Mast Cells Mobilize Myeloid-Derived Suppressor Cells and Treg Cells in Tumor Microenvironment via IL-17 Pathway in Murine Hepatocarcinoma Model
    Zhuoshun Yang, Biao Zhang, Dapeng Li, Meng Lv, Chunmei Huang, Guanxin Shen, Bo Huang · 2010 · PLoS ONE
81. Subsets, expansion and activation of myeloid-derived suppressor cells
    Eliana Ribechini, Verena Greifenberg, Sarah J. Sandwick, Manfred Bernhard Lutz · 2010 · Medical Microbiology and Immunology
82. On the armament and appearances of human myeloid-derived suppressor cells
    Isabel C. Poschke, Rolf W. Kiessling · 2012 · Clinical Immunology
83. Myeloid-derived suppressor cells in breast cancer
    Joseph Markowitz, Robert Wesolowski, Tracey L. Papenfuss, Taylor Brooks, William Edgar Carson · 2013 · Breast Cancer Research and Treatment
84. Metabolic reprogramming and metabolic dependency in T cells
    Ruoning Wang, Douglas R. Green · 2012 · Immunological Reviews
85. Myeloid‐derived suppressor cells: Important contributors to tumor progression and metastasis
    Elham Safarzadeh, Mona Orangi, Hamed Mohammadi, Farhad Babaie, Behzad Baradaran · 2017 · Journal of Cellular Physiology
86. Liposome-Based Drug Delivery Systems in Cancer Immunotherapy
    Zili Gu, Candido G. Da Silva, Koen van der Maaden, FERRY A. OSSENDORP, Luis Javier Cruz · 2020 · Pharmaceutics
87. Mouse CD11b+Gr-1+ Myeloid Cells Can Promote Th17 Cell Differentiation and Experimental Autoimmune Encephalomyelitis
    Huanfa Yi, Chunqing Guo, Xiaofei Yu, Daming Zuo, Xiang‐Yang Wang · 2012 · The Journal of Immunology
88. Prostaglandin E2/EP Signaling in the Tumor Microenvironment of Colorectal Cancer
    Rei Mizuno, Kenji Kawada, Yoshiharu Sakai · 2019 · International Journal of Molecular Sciences
89. Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma
    Reyisa Bughda, Paraskevi Dimou, Reena R. D’Souza, Astero Klampatsa · 2021 · ImmunoTargets and Therapy
90. Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer
    Shevchenko, Ivan, Karakhanova, Svetlana, Soltek, Sabine, Link, Julia, Bayry, Jagadeesh, Werner, Jens, Umansky, Viktor, Bazhin, Alexandr V. · 2013 · International Journal of Cancer
91. The immuno-pathophysiology of multiple sclerosis
    Gregory F. Wu, E. Álvarez · 2011 · Neurologic clinics
92. Immunosenescence and cancer
    Graham Pawelec, Evelyna Derhovanessian, Anis Larbi · 2010 · Critical Reviews in Oncology/Hematology
93. Immunosuppressive Myeloid Cells’ Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy
    Neha Kamran, Padma Kadiyala, Meghna Saxena, Marianela Candolfi, Youping Li, Mariela A. Moreno-Ayala, Nicholas Saleem Raja, Diana Shah, Pedro Ricardo Lowenstein, Maria Graciela Castro · 2017 · Molecular Therapy
94. Modulation of anti-tumor immunity by the brain’s reward system
    Tamar L. Ben-Shaanan, Maya Schiller, Hilla Azulay‐Debby, Ben Korin, Nadia Boshnak, Tamar Koren, Maria Krot, Jivan Shakya, Michal Amit Rahat, Fahed Hakim et al. · 2018 · Nature Communications
95. Pharmacological effects of icariin
    Chun‐Yang He, Ze Wang, Jingshan Shi · 2020 · Advances in pharmacology
96. Prostaglandin E2 and programmed cell death 1 signaling coordinately impair CTL function and survival during chronic viral infection
    Jonathan H. Chen, Curtis J. Perry, Yao‐Chen Tsui, Matthew M. Staron, Ian A. Parish, Claudia X. Dominguez, Daniel W Rosenberg, Susan M. Kaech · 2015 · Nature Medicine
97. Arginine Deprivation and Immune Suppression in a Mouse Model of Alzheimer's Disease
    Matthew J. Kan, Jennifer E. Lee, Joan G. Wilson, Angela L. Everhart, Candice M. Brown, Andrew N. Hoofnagle, Marilyn Jansen, Michael Peter Vitek, Michael Dee Gunn, Carol A. Colton · 2015 · Journal of Neuroscience
98. Myeloid-Derived Suppressor Cells in Cancer: Therapeutic, Predictive, and Prognostic Implications
    Claudia Marcela Diaz-Montero, J. H. Finke, Alberto J. Montero · 2014 · Seminars in Oncology
99. Aptamer-Mediated Blockade of IL4Rα Triggers Apoptosis of MDSCs and Limits Tumor Progression
    Felix Roth, Adriana C. De La Fuente, Jennifer L. Vella, Alessia Zoso, Luca Inverardi, Paolo Serafini · 2012 · Cancer Research
100. Ocular Immune Privilege and Transplantation
     Andrew W. Taylor · 2016 · Frontiers in Immunology